Avant Diagnostics Inc Stock
Equities
US05350M1062
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2021 | Avant Diagnostics : AvidXchange Shares Fall in Trading Debut | MT |
2021 | Avant Diagnostics : AvidXchange Prices IPO at $25 Per Share | MT |
Managers | Title | Age | Since |
---|---|---|---|
Michael Ruxin
CEO | Chief Executive Officer | 78 | 17-11-30 |
Thomas Chilcott
DFI | Director of Finance/CFO | 56 | 20-09-23 |
Glenn D. Hoke
CTO | Chief Tech/Sci/R&D Officer | - | 16-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 18-05-24 |
Michael Ruxin
CEO | Chief Executive Officer | 78 | 17-11-30 |
Director/Board Member | 43 | - |
1st Jan change | Capi. | |
---|---|---|
-17.60% | 11.07B | |
+39.11% | 3.16B | |
-20.67% | 2B | |
-29.30% | 1.46B | |
+11.45% | 966M | |
-6.33% | 718M | |
-30.75% | 430M | |
-51.02% | 348M | |
-2.58% | 286M |
- Stock Market
- Equities
- Stock